Help Close the Biggest Diagnostic Gap in Healthcare

We have broad patents covering AI-ECGs. This technology will give doctors and nurses the ability to detect heart disease, the world’s leading cause of death, much earlier. With Mayo Clinic as an early AI-ECG adopter and Medicare reimbursement already confirmed starting January 2025, now’s your chance to invest before FDA submission and full-scale commercialization begins, which could see the share price skyrocket.